Effects of ER-37328 on primary tumor, liver metastasis, and life span in a murine Colon 38 orthotopic transplantation model

Molecular Cancer Therapeutics

Volumn 2, Issue 1, 2003, Pages 59-64

  Nakamura, Katsuji ^a   Taniguchi, Tomoyoshi ^a   Funahashi, Yasuhiro ^a   Yoshimatsu, Kentaro ^a  

^a EISAI CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAZOLE DERIVATIVE; ER37328; ETOPOSIDE; PYRIMIDINE DERIVATIVE;

ANIMAL; ARTICLE; C57BL MOUSE; CELL DIVISION; COLON TUMOR; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; HUMAN; LIVER TUMOR; METASTASIS; MOUSE; MOUSE STRAIN; PATHOLOGY; SURVIVAL; TIME; XENOGRAFT;

ANIMALS; CARBAZOLES; CELL DIVISION; COLONIC NEOPLASMS; ETOPOSIDE; FEMALE; HUMANS; LIVER NEOPLASMS; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; NEOPLASM METASTASIS; PYRIMIDINES; SURVIVAL ANALYSIS; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0141799764     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Hande, K. R. Clinical applications of anticancer drugs targeted to topoisomerase II. Biochim. Biophys. Acta, 400: 173-184, 1998. (Pubitemid 28475102)
2. O'Dwyer, P. J., Leyland-Jones, B., Alonso, M. T., Marsoni, S., and Wittes, R. E. Etoposide (VP-16-213). Current status of an active anticancer drug. N. Engl. J. Med., 312: 692-700, 1985. (Pubitemid 15134707)
3. Belani, C. P., Doyle, L. A., and Aisner, J. Etoposide: current status and future perspectives in the management of malignant neoplasms. Cancer Chemother. Pharmacol., 34(Suppl.): S118-S126, 1994. (Pubitemid 24264056)
4. Ihde, D. C. Chemotherapy of lung cancer. N. Engl. J. Med., 327: 1434-1441, 1992.
5. Richie, J. P. Detection and treatment of testicular cancer. CA Cancer J. Clin., 43: 151-175, 1993. (Pubitemid 23155973)
6. Hortobagyi, G. N. Anthracyclines in the treatment of cancer. An overview. Drugs, 54(Suppl. 4): 1-7, 1997. (Pubitemid 27487789)
7. Urba, W. J., and Longo, D. L. Hodgkin's disease. N. Engl. J. Med., 326: 678-687, 1992.
8. Fisher, R. I., Gaynor, E. R., Dahlberg, S., Oken, M. M., Grogan, T. M., Mize, E. M., Glick, J. H., Coltman, C. A., Jr., and Miller. T. P. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N. Engl. J. Med., 328: 1002-1006, 1993.
9. Tranum, B. L., McDonald, B., Thigpen, T., Vaughn, C., Wilson, H., Maloney, T., Costanzi, J., Bickers, J., el Mawli, N. G., Palmer, R., Hoogstraten, B., Heilburn, L., and Rasmusen, S. Adriamycin combinations in advanced breast cancer. A Southwest Oncology Group Study. Cancer (Phila.), 49: 835-839, 1982. (Pubitemid 12184079)
10. Nakamura, K., Sugumi, H., Yamaguchi, A., Uenaka, T., Kotake, Y., Okada, T., Kamata, J., Niijima, J., Nagasu, T., Koyanagi, N., Yoshino, H., Kitoh, K., and Yoshimatsu, K. Antitumor activity of ER-37328, a novel carbazole topoisomerase II inhibitor. Mol. Cancer Ther., 1: 169-175, 2002.
11. Sinha, B. K. Topoisomerase inhibitors. A review of their therapeutic potential in cancer. Drugs, 49: 11-19, 1995.
12. Nitiss, J. L., and Beck, W. T. Antitopoisomerase drug action and resistance. Eur. J. Cancer, 32A: 958-966, 1996.
13. Von Hoff, D. D. There are no bad anticancer agents, only bad clinical trial designs - twenty-first Richard and Hinda Rosenthal Foundation Award Lecture. Clin. Cancer Res., 4: 1079-1086, 1998. (Pubitemid 28213317)
14. Von Hoff, D. D., Goodwin, A. L., and Garcia, L. Advances in the treatment of patients with pancreatic cancer: improvement in symptoms and survival time. The San Antonio Drug Development Team. Br. J. Cancer, 78(Suppl. 3): 9-13, 1998.
15. Fidler, I. J. Critical factors in the biology of human cancer metastasis: twenty-eighth G. H. A. Clowes memorial award lecture. Cancer Res., 50: 6130-6138, 1990. (Pubitemid 20323663)
16. Shirasaka, T., Nakano, K., Takechi, T., Satake, H., Uchida, J., Fujioka, A., Saito, H., Okabe, H., Oyama, K., Takeda, S., Unemi, N., and Fukushima, M. Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2, 4-dihydroxy-pyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats. Cancer Res., 56: 2602-2606, 1996. (Pubitemid 26171684)
17. Wang, X., Fu, X., Brown, P. D., Crimmin, M. J., and Hoffman, R. M. Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. Cancer Res., 54: 4726-4728, 1994. (Pubitemid 24276502)
18. Fidler, I. J. Orthotopic implantation of human colon carcinomas into nude mice provides a valuable model for the biology and therapy of metastasis. Cancer Metastasis Rev., 10: 229-243, 1991.
19. Funahashi, Y., Koyanagi, N., Sonoda, J., Kitoh, K., and Yoshimatsu, K. Rapid development of hepatic metastasis with high incidence following orthotopic transplantation of murine colon 38 carcinoma as intact tissue in syngeneic C57BL/6 mice. J. Surg. Oncol., 71: 83-90, 1999. (Pubitemid 29288484)
20. Funahashi, Y., Koyanagi, N., and Kitoh, K. Effect of E7010 on liver metastasis and life span of syngeneic C57BL/6 mice bearing orthotopically transplanted murine Colon 38 tumor. Cancer Chemother. Pharmacol., 47: 179-184, 2001. (Pubitemid 32662324)
21. Yamori, T., Matsunaga, A., Sato, S., Yamazaki, K., Komi, A., Ishizu, K., Mita, I., Edatsugi, H., Matsuba, Y., Takezawa, K., Nakanishi, O., Kohno, H., Nakajima, Y., Komatsu, H., Andoh, T., and Tsuruo, T. Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel. Cancer Res., 59: 4042-4049, 1999. (Pubitemid 29393575)
22. Fidler, I. J., Wilmanns, C., Staroselsky, A., Radinsky, R., Dong, Z., and Fan, D. Modulation of tumor cell response to chemotherapy by the organ environment. Cancer Metastasis Rev., 13: 209-222, 1994. (Pubitemid 24220006)
23. Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M., and Pastan, I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc. Natl. Acad. Sci. USA, 84: 265-269, 1987. (Pubitemid 17013615)
24. Goldstein, L. J., Galski, H., Fojo, A., Willingham, M., Lai, S. L., Gazdar, A., Pirker, R., Green, A., Crist, W., Brodeur, G. M., Lieber, M., Cossman, J., Gottesman, M. M., and Pastan, I. Expression of a multidrug resistance gene in human cancers. J. Natl. Cancer Inst., 81: 116-124, 1989. (Pubitemid 19031328)
25. Mizoguchi, T., Yamada, K., Furukawa, T., Hidaka, K., Hisatsugu, T., Shimazu, H., Tsuruo, T., Sumizawa, T., and Akiyama, S. Expression of the MDR1 gene in human gastric and colorectal carcinomas. J. Natl. Cancer Inst., 82: 1679-1683, 1990.